Emergence of lineage III of Shigella sonnei ST152 belonging to a high-risk clone harboring the bla

Beta-lactams Betalactámicos Multi-resistance Multirresistencia Peru Perú Shigella sonnei

Journal

Revista Argentina de microbiologia
ISSN: 0325-7541
Titre abrégé: Rev Argent Microbiol
Pays: Argentina
ID NLM: 8002834

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 09 05 2023
revised: 21 02 2024
accepted: 26 02 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: aheadofprint

Résumé

Multidrug-resistant Shigella sonnei ST152, global lineage III, is a high-risk clone, whose dissemination has limited therapeutic options for shigellosis. This study aimed to characterize two isolates of S. sonnei, which were recovered in Lima, Peru, during November 2019, exhibiting resistance to extended-spectrum cephalosporins and quinolones, and concurrently harboring bla

Identifiants

pubmed: 38845247
pii: S0325-7541(24)00040-3
doi: 10.1016/j.ram.2024.02.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Arturo Gonzales Rodriguez (A)

Facultad de Medicina Humana, Universidad de Piura, Peru. Electronic address: arturo.gonzales@udep.edu.pe.

Edgar Gonzales Escalante (E)

Facultad de Medicina Humana, Universidad de Piura, Peru.

Lizet Lezameta Abarca (L)

Facultad de Medicina, Universidad Peruana Cayetano Heredia, Peru; Laboratorio de Resistencia Antibiótica e Inmunopatología, Universidad Peruana Cayetano Heredia, Peru; Clínica Centenario Peruano Japonesa, Lima, Peru.

Jordana Atenas Gutierrez (J)

Facultad de Medicina Humana, Universidad de Piura, Peru.

Classifications MeSH